SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank -- Ignore unavailable to you. Want to Upgrade?


To: Jenna who wrote (89967)3/24/2000 12:11:00 AM
From: Jenna  Read Replies (2) | Respond to of 120523
 
LCBM another biotech for tomorrow. The 'third tier' biotechs are now starting to move up while the 'second tier' are still exploding (IMMU,GILD, AVGN, MOGN) and the 'first tier' like GLGC, BGEN,ALKS, IMNX,AMGN, MLNM, etc are in downtrends already. Most likely I will not be holding any biotechs through the weekend. I still had one biotech mutual fund but like I expected, it was a relief rally for the 'better biotechs' and I got out while the getting was good. This was a few month hold so I did lose about 40% of the gains, but I had already sold another 3 through the beginning of March and this was the 'best one' but I used this few days of gains to save an even greater loss of 'profit'.. Waiting for them to map the fruit fly genes, I grew restless and wanted to save the 3 digit profit from disintegrating completely.

From today's watch list:

Still bullish on IMCL (reports on Monday looking for $-0.17 from $-0.32),
IMMU, GLGC (but guarded), ALKS, VIRS, CEGE, SEBL..



To: Jenna who wrote (89967)3/24/2000 7:53:00 AM
From: WaveSeeker  Respond to of 120523
 
Jenna,

I still think GALT has the potential as you described. They are well-positioned in the network semiconductor space and have some other tech initiatives that will make them a major player.

WS